Cargando…
Development of Anti-OSCAR Antibodies for the Treatment of Osteoarthritis
Osteoarthritis (OA) is the most common joint disease that causes local inflammation and pain, significantly reducing the quality of life and normal social activities of patients. Currently, there are no disease-modifying OA drugs (DMOADs) available, and treatment relies on pain relief agents or arth...
Autores principales: | Kim, Gyeong Min, Park, Doo Ri, Nguyen, Thi Thu Ha, Kim, Jiseon, Kim, Jihee, Sohn, Myung-Ho, Lee, Won-Kyu, Lee, Soo Young, Shim, Hyunbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604876/ https://www.ncbi.nlm.nih.gov/pubmed/37893216 http://dx.doi.org/10.3390/biomedicines11102844 |
Ejemplares similares
-
Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation
por: Park, Doo Ri, et al.
Publicado: (2020) -
A Novel Synthetic Antibody Library with Complementarity-Determining Region Diversities Designed for an Improved Amplification Profile
por: Bai, Xuelian, et al.
Publicado: (2022) -
An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody
por: Kim, Dae Gyu, et al.
Publicado: (2020) -
Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
por: Shim, Hyunbo
Publicado: (2020) -
Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
por: Kim, Ji Woong, et al.
Publicado: (2022)